Background: This study aims to explore the clinical utility of Evolocumab in combination with an e-Health System: Swiss Prospective Observational Study in Patients with clinical Atherosclerotic Cardiovascular Disease. Sponsor: Amgen, Switzerland Trial Status: recruiting Enrolling Centers: Switzerland Core Study Team:
© Christian Mueller, 2012 - 2021 │ DisclaimerImprintWebmaster │ Last Update: December 2021
ECARA
Ina-Maria Ferel, Ph.D.